''Unfavorable exchange rates impact on results with quarterly revenue increasing slightly over the previous quarter to $11.54m from $11.46m and underlying EBITDA down 9% to $2.95m
The Subscription Business (Track) has begun to stabilise, although revenue and EBITDA were lower than the previous quarter.''
Earnings decreasing from previous qtr ???? Growth stock ????
IMO,
Valuation is contingent on Crowd Mobile delivering a sustained period of earnings growth
- Forums
- ASX - By Stock
- UNT
- Ann: June Quarter Trading Update-CM8.AX
Ann: June Quarter Trading Update-CM8.AX, page-2
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add UNT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.97M |
Open | High | Low | Value | Volume |
1.3¢ | 1.3¢ | 1.3¢ | $9.551K | 734.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 5130941 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 518236 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 5130941 | 0.013 |
13 | 2779513 | 0.012 |
3 | 902304 | 0.011 |
6 | 1488966 | 0.010 |
2 | 1100000 | 0.009 |
Price($) | Vol. | No. |
---|---|---|
0.014 | 518236 | 4 |
0.015 | 449000 | 3 |
0.016 | 715962 | 5 |
0.017 | 766142 | 4 |
0.018 | 1108178 | 3 |
Last trade - 14.34pm 13/11/2024 (20 minute delay) ? |
Featured News
UNT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online